SENS (Senseonics Holdings) EBIT per Share: $-1.85 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SENS Senseonics Holdings Inc SENS
56 GF Score
Price $5.11
GF Value $14.41
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Senseonics Holdings EBIT per Share?

Senseonics Holdings SENS -0.58% 56 EBIT per Share is $-1.85 as of Mar. 2026. GuruFocus rates SENS with a GF Score™ of 56/100 and a GF Value™ of $14.41 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 686 Medical Devices & Instruments companies, Senseonics Holdings ranks better than 50.44% on this metric.

Senseonics Holdings's EBIT per Share for the three months ended in Mar. 2026 was $-0.68. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.85.

During the past 3 years, the average EBIT per Share Growth Rate was 9.60% per year. During the past 5 years, the average EBIT per Share Growth Rate was 19.10% per year. During the past 10 years, the average EBIT per Share Growth Rate was -8.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Senseonics Holdings's EBIT per Share or its related term are showing as below:

SENS' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -805.2   Med: 10.1   Max: 45.7
Current: 9.6

During the past 12 years, the highest 3-Year average EBIT per Share Growth Rate of Senseonics Holdings was 45.70% per year. The lowest was -805.20% per year. And the median was 10.10% per year.

SENS's 3-Year EBIT Growth Rate is ranked better than
50.44% of 686 companies
in the Medical Devices & Instruments industry
Industry Median: 9.25 vs SENS: 9.60

Senseonics Holdings's EBIT for the three months ended in Mar. 2026 was $-31.14 Mil.


Senseonics Holdings  (NAS:SENS) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Senseonics Holdings EBIT per Share Related Terms


Senseonics Holdings EBIT per Share Historical Data

* Premium members only.

The historical data trend for Senseonics Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senseonics Holdings EBIT per Share Chart

Senseonics Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.53 5.20 -1.74 -2.23 -1.54

Senseonics Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.36 -0.33 -0.41 -0.43 -0.68
SENS
56GF Score
Senseonics Holdings Inc SENS
EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Senseonics Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Senseonics Holdings's EBIT per Share for the fiscal year that ended in Dec. 2025 is calculated as

EBIT per Share(A: Dec. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-64.162/41.728
=-1.54

Senseonics Holdings's EBIT per Share for the quarter that ended in Mar. 2026 is calculated as

EBIT per Share(Q: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-31.141/45.822
=-0.68

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-1.85 mean?
Senseonics Holdings (SENS) has a EBIT per Share of $-1.85 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Senseonics Holdings and its competitors. According to the industry distribution chart, Senseonics Holdings ranks #340 out of 686 companies in the Medical Devices & Instruments industry, placing it in the top 49.6%.
Is Senseonics Holdings' EBIT per Share too high?
Senseonics Holdings' current EBIT per Share is $-1.85. Based on the distribution chart, Senseonics Holdings ranks #340 out of 686 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Senseonics Holdings has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Senseonics Holdings' EBIT per Share compare to LAB and TMCI?
According to the Medical Devices & Instruments industry distribution chart, Senseonics Holdings ranks #340 out of 686 companies for EBIT per Share. This puts Senseonics Holdings in the upper half of its industry. The industry median EBIT per Share is 9.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.25, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Senseonics Holdings and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Senseonics Holdings's current EBIT per Share is $-1.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senseonics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Senseonics Holdings (SENS) is currently considered Possible Value Trap. The stock's GF Value™ is $14.41, compared to a current price of $5.11 — trading 64.5% below its estimated fair value. The current EBIT per Share is $-1.85. Senseonics Holdings' overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Senseonics Holdings (SENS), the current EBIT per Share is $-1.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Senseonics Holdings (SENS) Overvalued in 2026?

Based on GuruFocus' analysis, Senseonics Holdings stock appears to be undervalued. The current stock price of $5.11 is trading 64.5% below its estimated GF Value™ of $14.41. GuruFocus considers Senseonics Holdings to be Possible Value Trap.

Key valuation signals for SENS:

  • EBIT per Share: $-1.85
  • GF Value™: $14.41 vs. price of $5.11 (64.5% below fair value)
  • GF Score™: 56/100 with 3 warning signs

No single metric tells the full story. See the SENS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Senseonics Holdings Business Description

Other Exchanges 6L60:Germany
Address 20451 Seneca Meadows Parkway, Germantown, MD, USA, 20876-7005
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
56GF Score

Get the complete analysis for SENS

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.11
Price
$14.41
GF Value